RxDoctor Payments Data

Ciaran McNamee, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Boston, MANPI 1124019351

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (36.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Intuitive Surgical at 45.8% of the total. Reporting peaked in 2020 at $19,271 and has fallen 72.2% since, to $5,352 in 2025.

$45,136in general payments, 2019–2025

Across 78 payments — averaging $578.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$21K
  • Covidien LP$18K
  • Avyxa Pharma, LLC$4K
  • Genentech, Inc.$1K
  • F. Hoffmann-la Roche AG$715
  • Johnson & Johnson$149
  • plus $136 from 1 others
$882,620in research payments, 2019–2025

Across 76 payments — averaging $11,613 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$877K
  • F. Hoffmann-la Roche AG$6K

What the payments were for

  • Consulting fees$16,65037%
  • Speaking & faculty fees$2,7156%
  • Travel & lodging$8,63919%
  • Food & beverage$2,6196%
  • Education$14,50032%
  • Gifts$140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical47$20,678
Covidien LP12$17,953
Avyxa Pharma, LLC7$4,199
Genentech, Inc.6$1,305
F. Hoffmann-la Roche AG1$715
Johnson & Johnson(2 entities)4$149
Baxter Healthcare1$136

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,136 in reported general payments places this provider in the 85th percentile of 171 thoracic surgery (cardiothoracic vascular surgery) providers in Massachusetts.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Massachusetts

Medicare billing

Part B allowed, 2024
$123,257
Medicare patients
251
Services billed
627

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →